| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 分部间抵销(元) | - | - | - | - | -10,125,940.66 |
| 医药制造业务(元) | - | - | - | - | 831,842,219.71 |
| 儿科(元) | - | 162,109,635.44 | - | 182,874,123.88 | - |
| 妇科(元) | - | 60,694,518.50 | - | 81,338,912.79 | - |
| 骨伤科(元) | - | 393,755,306.92 | - | 384,152,869.84 | - |
| 呼吸系统用药(元) | - | 112,439,131.14 | - | 213,495,651.46 | - |
| 抗感染(元) | - | 72,779,241.92 | - | 77,698,100.45 | - |
| 心脑血管(元) | - | 633,197,400.93 | - | 530,494,346.50 | - |
| 提供服务(元) | 38,393,307.75 | - | 44,911,160.14 | - | - |
| 销售商品(元) | 919,354,339.60 | - | 789,337,815.49 | - | - |
| 其他(元) | - | 254,045,626.82 | - | 239,746,888.98 | 61,893,700.28 |
| 营业成本(元) | |||||
| 分部间抵销(元) | - | - | - | - | -17,353,686.47 |
| 医药制造业务(元) | - | - | - | - | 210,170,807.42 |
| 儿科(元) | - | 62,010,327.70 | - | 61,610,907.41 | - |
| 妇科(元) | - | 16,011,818.01 | - | 17,436,974.51 | - |
| 骨伤科(元) | - | 69,439,665.31 | - | 65,569,496.71 | - |
| 呼吸系统用药(元) | - | 28,172,094.06 | - | 50,260,934.38 | - |
| 抗感染(元) | - | 45,649,054.94 | - | 47,028,051.02 | - |
| 心脑血管(元) | - | 106,799,776.21 | - | 102,362,522.02 | - |
| 提供服务(元) | 18,693,363.92 | - | 39,664,702.60 | - | - |
| 销售商品(元) | 212,962,752.74 | - | 208,126,288.08 | - | - |
| 其他(元) | - | 147,473,855.38 | - | 126,356,857.49 | 47,633,126.83 |
| 毛利(元) | |||||
| 分部间抵销(元) | - | - | - | - | 7,227,745.81 |
| 医药制造业务(元) | - | - | - | - | 621,671,412.29 |
| 儿科(元) | - | 100,099,307.74 | - | 121,263,216.47 | - |
| 妇科(元) | - | 44,682,700.49 | - | 63,901,938.28 | - |
| 骨伤科(元) | - | 324,315,641.61 | - | 318,583,373.13 | - |
| 呼吸系统用药(元) | - | 84,267,037.08 | - | 163,234,717.08 | - |
| 抗感染(元) | - | 27,130,186.98 | - | 30,670,049.43 | - |
| 心脑血管(元) | - | 526,397,624.72 | - | 428,131,824.48 | - |
| 提供服务(元) | 19,699,943.83 | - | 5,246,457.54 | - | - |
| 销售商品(元) | 706,391,586.86 | - | 581,211,527.41 | - | - |
| 其他(元) | - | 106,571,771.44 | - | 113,390,031.49 | 14,260,573.45 |
| 毛利率(%) | |||||
| 分部间抵销(%) | - | - | - | - | -71.38 |
| 医药制造业务(%) | - | - | - | - | 74.73 |
| 儿科(%) | - | 61.75 | - | 66.31 | - |
| 妇科(%) | - | 73.62 | - | 78.56 | - |
| 骨伤科(%) | - | 82.36 | - | 82.93 | - |
| 呼吸系统用药(%) | - | 74.94 | - | 76.46 | - |
| 抗感染(%) | - | 37.28 | - | 39.47 | - |
| 心脑血管(%) | - | 83.13 | - | 80.70 | - |
| 提供服务(%) | 51.31 | - | 11.68 | - | - |
| 销售商品(%) | 76.84 | - | 73.63 | - | - |
| 其他(%) | - | 41.95 | - | 47.30 | 23.04 |
| 收入构成(%) | |||||
| 分部间抵销(%) | - | - | - | - | -1.15 |
| 医药制造业务(%) | - | - | - | - | 94.14 |
| 儿科(%) | - | 9.60 | - | 10.70 | - |
| 妇科(%) | - | 3.59 | - | 4.76 | - |
| 骨伤科(%) | - | 23.31 | - | 22.47 | - |
| 呼吸系统用药(%) | - | 6.66 | - | 12.49 | - |
| 抗感染(%) | - | 4.31 | - | 4.54 | - |
| 心脑血管(%) | - | 37.49 | - | 31.03 | - |
| 提供服务(%) | 4.01 | - | 5.38 | - | - |
| 销售商品(%) | 95.99 | - | 94.62 | - | - |
| 其他(%) | - | 15.04 | - | 14.02 | 7.00 |
| 毛利构成(%) | |||||
| 分部间抵销(%) | - | - | - | - | 1.12 |
| 医药制造业务(%) | - | - | - | - | 96.66 |
| 儿科(%) | - | 8.25 | - | 9.79 | - |
| 妇科(%) | - | 3.68 | - | 5.16 | - |
| 骨伤科(%) | - | 26.73 | - | 25.71 | - |
| 呼吸系统用药(%) | - | 6.94 | - | 13.17 | - |
| 抗感染(%) | - | 2.24 | - | 2.48 | - |
| 心脑血管(%) | - | 43.38 | - | 34.55 | - |
| 提供服务(%) | 2.71 | - | 0.89 | - | - |
| 销售商品(%) | 97.29 | - | 99.11 | - | - |
| 其他(%) | - | 8.78 | - | 9.15 | 2.22 |